News Combination between Novozymes and Chr. Hansen approved by the Novozymes shareholders Staff March 30, 2023 Please read the announcement in PDF Attachment 2023_50_Combination_between_Novozymes_and_Chr._Hansen_approved_by_the_Novozymes_shareholders Continue Reading Previous GSK and SCYNEXIS Announce an Exclusive Agreement to Commercialise and Further Develop Brexafemme (ibrexafungerp), a Novel, First-in-Class Medicine to Treat Fungal InfectionNext Combination between Novozymes and Chr. Hansen approved by Novozymes’ shareholders More Stories News The WISH Clinic Partnering With Clara Care to Bring Specialized Wound Care Directly to Patients in the Convenience of Their Homes Staff June 15, 2024 News Chinese Team Secures “Best Showpiece Award” at the 52nd UIBC International Competition for Young Bakers with Angel Yeast’s Support Staff June 15, 2024 Cancer Clinical Trial EHR News Pharmaceutical Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress Staff June 15, 2024